regional market

Sales & Marketing

In a landscape shaped by regulatory complexity, POA Pharma is demonstrating that smart, regionally tailored growth can outperform scale.

R&D

Questions of supply chain security and resiliency have been growing in recent years.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.